The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein

Jan 8, 2008The American journal of clinical nutrition

Low-glycemic-index diet in type 2 diabetes lowers inflammation but does not change blood sugar control after one year

AI simplified

Abstract

A low-glycemic index (GI) diet resulted in a 30% lower C-reactive protein level compared to a high-GI diet.

  • Body weight and long-term glycated hemoglobin (HbA1c) levels did not significantly differ among the high-GI, low-GI, and low-carbohydrate diets.
  • Fasting glucose levels were higher after 12 months on the low-GI diet, while 2-hour post-load glucose levels were lower.
  • The low-GI diet led to a 12% increase in overall mean triacylglycerol and a 4% decrease in HDL cholesterol compared to the low-carbohydrate diet.
  • The difference in the ratio of total to HDL cholesterol among the diets disappeared by 6 months.
  • The low-GI diet was associated with a 30% reduction in C-reactive protein compared to the high-GI diet.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • ๐Ÿ“š7 fresh studies
  • ๐Ÿ“plain-language summaries
  • โœ…direct links to original studies
  • ๐Ÿ…top journal indicators
  • ๐Ÿ“…weekly delivery
  • ๐Ÿง˜โ€โ™‚๏ธalways free